Detection of soluble TRAIL in HBV infected patients and its clinical implications

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

209

HTML

2275

Tables (1-4)

134

Sum=2618

Dec 15, 2002 (publication date) through May 7, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Dec 15, 2002; 8(6): 1077-1080
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1077

Table 2 Analysis of corelation between the expression of sTRAIL and clinical indices of hepatitis B

	sTRAIL	Clinical indices		Correlativity coeffficient
HBV carrier	876.88 ± 369.59	ALT	28.38 ± 5.09
		Tbil	17.73 ± 3.34
		ALB	39.5 ± 1.20
Chronic hepatitis	1494.97 ± 533.24	ALT	173.61 ± 135.32	r = 0.496(P < 0.01)
		Tbil	66.79 ± 61.73
		ALB	32.95 ± 5.86	r = -0.392(P < 0.05)
HBV infectious related cirrhosis	1375.00 ± 526.08	ALT	150.36 ± 132.72
		Tbil	82.83 ± 118.00
		ALB	34.01 ± 5.79
HBV infectious related liver cancer	1561 ± 449.56	ALT	85.67 ± 48.76
		Tbil	58.81 ± 24.43
		ALB	36.63 ± 10.07

Citation: Han LH, Sun WS, Ma CH, Zhang LN, Liu SX, Zhang Q, Gao LF, Chen YH. Detection of soluble TRAIL in HBV infected patients and its clinical implications. World J Gastroenterol 2002; 8(6): 1077-1080
URL: https://www.wjgnet.com/1007-9327/full/v8/i6/1077.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i6.1077